Annals of Pediatric Cardiology
About us | Current Issue | Archives | Ahead of Print | Instructions | Submission | Subscribe | Advertise | Contact | Login 
 


 

 
     
    Advanced search
 

 
 
     
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  


    Indications
    Site of Balloon ...
    Balloon Size
    Post -Dilatation...
    Arterial Insuffi...
    Aortic Stents
    Conclusions
    References

 Article Access Statistics
    Viewed2140    
    Printed152    
    Emailed0    
    PDF Downloaded367    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 


 
INVITED COMMENT Table of Contents   
Year : 2009  |  Volume : 2  |  Issue : 2  |  Page : 116-119
Transcatheter interventions in critically ill neonates and infants with aortic coarctation


Division of Pediatric Cardiology, The University of Texas/Houston Medical School, 6410 Fannin Street, UTPB Suite # 425, Houston, TX 77030, USA

Click here for correspondence address and email

Date of Web Publication12-Dec-2009
 

How to cite this article:
Rao P S. Transcatheter interventions in critically ill neonates and infants with aortic coarctation. Ann Pediatr Card 2009;2:116-9

How to cite this URL:
Rao P S. Transcatheter interventions in critically ill neonates and infants with aortic coarctation. Ann Pediatr Card [serial online] 2009 [cited 2019 Apr 18];2:116-9. Available from: http://www.annalspc.com/text.asp?2009/2/2/116/58312


Surgical correction of aortic coarctation (AC) was concurrently introduced by Crafoord and Nylin, [1] Gross and Hufnagel [2] in the early 1940s. Since that time surgical therapy has become the preferred treatment option for AC. Nearly three decades ago, Gruntzig's technique of balloon angioplasty [3] was adopted by Sos, [4] Singer, [5] Sperling [6] and colleagues for enlargement of coarcted aortic segments in a postmortem specimen, postsurgical recoarctation, and native coarctation, respectively. Subsequently, other cardiologists used this technique to treat native AC.

Despite an initial report of poor results, [7] subsequent experience with balloon angioplasty appears encouraging and was reviewed elsewhere. [8],[9],[10],[11],[12] The editorial critique on the results of the first successful case series of balloon angioplasty for native AC read [13] : "Now that we can dilate, should we?" [14] This was followed by reports of formation of aneurysms following balloon angioplasty of AC; [15],[16] which in retrospect, may have been related to the use of very large balloons. The foregoing events cast skepticism on the usefulness of balloon angioplasty in the management of AC among pediatric cardiology and the cardiovascular surgical community. Shortly thereafter, the results of Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) registry for native ACs [17] and post-surgical aortic recoarcatations [18] were published. Reduction in peak-to-peak systolic pressure gradient following balloon angioplasty for native coarctation was from 48 ± 19 mmHg to 12 ± 11 mmHg while that for post-surgical recoarctation was from 42 ± 20 mmHg to 9 ± 3 mmHg and these results were not statistically different (P > 0.05). The complication rates (9.9% vs. 8.5%) and mortality rates (0.7% vs. 2.5%) were also not different (P = 0.05 to 0.1).

The conclusion for native ACs was "the question remains not can it be done, but should it be done?," whereas the conclusion for post-surgical aortic recoarctation was "… balloon angioplasty for relief of residual or recurrent aortic coarctation offers an acceptable alternative to repeat surgical repair" despite the fact that results were similar or even better for native AC. I questioned this interpretation [19] stating that "this is not logical and that objectivity of scientific interpretation should be maintained." Subsequently, additional arguments advocating balloon angioplasty as a first-line therapeutic option in the management of native AC were presented. [20],[21]

While treatment of native AC by balloon angioplasty was initially controversial, [14],[17],[19],[20],[21],[22],[23],[24] it gradually gained acceptance in the management of children with native coarctation. However, it remained controversial in the neonates and young infants. [22],[25],[26],[27]

In this issue of the Journal, Francis et al. [28] present data on 10 infants (mean age = 2.9 weeks) who underwent transcatheter intervention (balloon angioplasty in five and stents in five) for management of severe AC with left ventricular dysfunction. Peak systolic pressure gradient across the coarctation was reduced from 51 ± 12 mmHg to 8.7±6.7 mmHg. More importantly, the left ventricular dysfunction abated and patients were discharged home 6.5±3.4 days after procedure. However, all patients developed restenosis, requiring elective surgical repair or repeat balloon dilatation. The authors conclude that balloon dilatation with or without stent is an effective, though temporary, palliation for sick infants with severe AC. This is a well-written paper addressing the difficult issue of AC in neonates and young infants. However, the paper includes some issues worthy of further exploration: Authors have not clearly stated the reasons for choosing balloon angioplasty over stent. While they had seven patients with discrete narrowing and three had arch hypoplasia, five had stents implanted, meaning that they implanted stents in some patients with discrete coarctation. Although Lababidi et al. [13] were amongst the first to report balloon dilatation of AC, Sperling, [6] Lock, [7] Finley, [29] Brodsky, [30] Cooper [31] and Suarez de Lezo [32] had reported successful dilatation of AC earlier. They misquoted our papers [25],[33] in that we preferred surgery over balloon angioplasty; indeed, our preference and recommendations were to use balloon angioplasty as first-line therapeutic option. [25],[33] Finally, the authors [28] did not acknowledge prior reports in early 1990s in which Salauddin [34] and Rao [35] from our group reported use of balloon angioplasty for exactly the same reason Francis et al. [28] used transcatheter intervention. Despite these limitations, the authors' data add value and supplement the previously reported experience with transcatheter intervention for AC. Furthermore, this paper provides an opportunity to discuss several issues germane to the management of coarctation of aorta in neonates and young infants.


   Indications Top


Indications for balloon angioplasty are similar to those used for surgical intervention: Significant hypertension and/or congestive heart failure. While the controversy over routine use of balloon angioplasty in treatment of neonatal and infant coarctations continues, it may certainly be utilized in special circumstances, [21] namely, neonates with shock-like picture and severe cardio-respiratory decompensation; [28],[35] severe myocardial dysfunction, secondary to "hypertensive cardiomyopathy" (due to coarctation), [34] prior cerebral hemorrhage, [21] and liver dysfunction associated with biliary atresia. [21] We found balloon angioplasty to be useful in these situations and recommend it as first-line therapeutic option.


   Site of Balloon Catheter Entry Top


Potential for arterial damage exists, especially in neonates and young children. Therefore, use of umbilical artery approach in neonates [35],[36],[37],[38] and anterograde approach transvenously [37],[38],[39] via a transposed aorta or through the ventricular septal defect, when feasible, should be undertaken. When femoral artery is catheter entry site, low profile balloons (for example Tyshak II, Minighost, MiniTyshak balloon catheters [Braun] and others) that can be introduced through 3 or 4 French sheaths should be utilized.


   Balloon Size Top


The diameter of the balloon selected for angioplasty should be carefully chosen. Small balloons do not produce adequate relief of obstruction and large balloons may produce aortic rupture or aneurysm formation. Initial balloon dilatation is performed with a balloon whose diameter is an average of aortic isthmus or transverse aortic arch and descending aorta at the level of diaphragm. If there is no adequate relief of obstruction (i.e. gradient < 20 mmHg) and angiographic improvement, repeat dilatation at the same sitting with a balloon as large as the diameter of the descending aorta at the level of diaphragm should be undertaken. [40] It is extremely rare that the balloon size should ever need to exceed the descending aortic size.


   Post -Dilatation Catheter Manipulation Top


Tips of guide wires or catheters should not be manipulated over the freshly dilated coarctation segment to avoid aortic perforation. [29] A guide wire should always be left in place across the coarctation segment, and all angiographic and balloon-dilatation catheters should be exchanged over a guide wire.


   Arterial Insufficiency Top


Evaluation of arterial insufficiency and limb growth retardation [41] in a group of children who underwent transfemoral artery interventions suggested compromised superficial femoral artery circulation without evidence of limb growth retardation during follow-up of one to eight years (mean, 3.5 years). Evaluation of arterial insufficiency by Doppler, [42] by measurement of ankle to brachial blood pressure index (ABI) [41] and/or by angiography, [41] should be incorporated into evaluation protocol during the follow-up for the primary cardiac condition.


   Aortic Stents Top


Stenotic vascular lesions can be dilated by balloon angioplasty. However, the elastic recoil of the vessel wall may return the vessel lumen to the pre-dilatation diameter following removal of the balloon catheter. Such recoil and vascular dissection, if any, following balloon dilatation can be circumvented with implantation of endovascular stents. Additional principles of stent management, historical aspects of stent development, types of stents, technique of stent deployment and results of stent therapy will not be reviewed here because of limits of space. The interested reader is referred elsewhere [43],[44] for further discussion of these issues.

Because of growth issues and the need for large sheaths for stent implantation, most cardiologists limit stent usage to adolescents and adults, although a few have advocated their use in younger children. [45],[46],[47],[48] Even when large stents (for example, Palmaz P-8 series and Genesis XD) are used, they may not be dilatable to adult size aorta. Use of many of these stents may result in subjecting the patient to a more complicated surgical repair at a later date. [49] The small stents used by Francis et al. [28] indeed produced need for surgical intervention. Therefore, alternative solutions such as use of biodegradable stents [50],[51] or growth stents [52] should be considered. Biodegradable stents keep the coarcted aortic segment open for a three to six month period, after which the stents dissolve. By then, the ratio of the normal aortic tissue to abnormal tissue may be in favor of the infant, thus preventing recurrence of significant narrowing. However, this hypothesis should be tested in appropriate animal models and stent delivery systems miniaturized so that they can be used in neonates and young infants. Similarly, growth stents may allow re-dilatation at a later date; although the limited experience is encouraging; [52] larger clinical trials are needed to confirm the utility of this concept. [53]


   Conclusions Top


In summary, the paper by Francis and associates which describes the utility of transcatheter intervention in neonates and young infants with critical coarctation of the aorta and left ventricular dysfunction, re-emphasizes prior reports advocating such approaches. Selection of site of entry for the procedure to minimize arterial damage, use of appropriate size balloon for angioplasty, avoiding manipulation of tips of catheters/guide wires across the freshly dilated coarctation segment, and incorporation of some method of evaluation of femoral artery sufficiency at the time of follow-up of the primary cardiac defect are germane to the success of the procedure. Avoiding use of stents in neonates and small infants and/or developing alternative strategies such as biodegradable stents or growth stents is recommended.

 
   References Top

1.Crafoord O, Nylin G. Congenital coarctation of the aorta and its surgical treatment. J Thorac Cardiovasc Surg 1945;14:347-61.  Back to cited text no. 1      
2.Gross RE, Hufnagl CA. Coarctation of the aorta: Experimental studies regarding its surgical correction. N Engl J Med 1945;233:287-91.  Back to cited text no. 2      
3.Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary artery stenosis: Percutaneous transluminal coronary angioplasty. New Engl J Med 1979;301:61-8.  Back to cited text no. 3      
4.Sos T, Sniderman KW, Rettek-Sos B, Strupp A, Alonso DR. Percutaneous transluminal dilatation of coarctation of thoracic aorta post mortem. Lancet 1979;2:970-1.  Back to cited text no. 4      
5.Singer MI, Rowen M, Dorsey TJ. Transluminal aortic balloon angioplasty for coarctation of the aorta in the newborn. Am Heart J 1982;103:131-2.  Back to cited text no. 5      
6.Sperling DR, Dorsey TJ, Rowen M, Gazzaniga AB. Percutaneous transluminal angioplasty of congenital coarctation of the aorta. Am J Cardiol 1983;51:562-4.  Back to cited text no. 6      
7.Lock JE, Bass JL, Amplatz K, Fuhrman BP, Castaneda-Zuniga W. Balloon dilation angioplasty of aortic coarctation in infants and children. Circulation 1983;68:109-16.  Back to cited text no. 7      
8.Rao PS. Transcatheter treatment of pulmonary stenosis and coarctation of the aorta: Experience with percutaneous balloon dilatation. Br Heart J 1986;56:250-8.  Back to cited text no. 8      
9.Rao PS. Balloon angioplasty of aortic coarctation: A review. Clin Cardiol 1989;12:618-28.  Back to cited text no. 9      
10.Rao PS, Chopra PS. Role of balloon angioplasty in the treatment of aortic coarctation. Ann Thorac Surg 1991;52:621-31.  Back to cited text no. 10      
11.Rao PS. Balloon angioplasty of native aortic coarctation, In: Rao PS, editor. Transcatheter Therapy in Pediatric Cardiology. New York, NY: Wiley-Liss; 1993. p. 153-96.  Back to cited text no. 11      
12.Rao PS. Long-term follow-up results after balloon dilatation of pulmonic stenosis, aortic stenosis, and coarctation of the aorta: A review. Prog Cardiovasc Dis 1999;42:59-74.  Back to cited text no. 12      
13.Lababidi ZA, Daskalopoulos DA, Stoeckle H Jr. Transluminal balloon coarctation angioplasty: Experience with 27 patients. Am J Cardiol 1984;54:1288-91.  Back to cited text no. 13      
14.Lock JE. Now that we can dilate, should we? (Editorial). Am J Cardiol 1984;54:1360.  Back to cited text no. 14      
15.Marvin WJ, Mahoney LT, Rose EF. Pathologic sequelae of balloon dilation angioplasty of unoperated coarctation of the aorta in children (Abstract). J Am Coll Cardiol 1986;7:117A.  Back to cited text no. 15      
16.Cooper RS, Ritter SB, Rothe WB, Chen CK, Griepp R, Golinko RJ. Angioplasty for coarctation of the aorta: Long-term results. Circulation 1987;75:600-4.  Back to cited text no. 16      
17.Tynan M, Finley JP, Fontes V, Hess J, Kan J. Balloon angioplasty for the treatment of native coarctation: Results of Valvuloplasty and Angioplasty of Congenital Anomalies Registry. Am J Cardiol 1990;65:790-2.  Back to cited text no. 17      
18.Hellenbrand WE, Allen HD, Golinko RJ, Hagler DJ, Lutin W, Kan J. Balloon angioplasty for aortic recoarctation: Results of Valvuloplasty and Angioplasty of Congenital Anomalies Registry. Am J Cardiol 1990;65:793-7.  Back to cited text no. 18      
19.Rao PS. Balloon angioplasty of native coarctations (Letter). Am J Cardiol 1990;66:1401.  Back to cited text no. 19      
20.Rao PS. Should balloon angioplasty be used instead of surgery for native aortic coarctation?. Br Heart J 1995;74:578-9.  Back to cited text no. 20      
21.Rao PS. Should balloon angioplasty be used as a treatment of choice for native aortic coarctations? J Invasive Cardiol 1996;8:301-13.  Back to cited text no. 21      
22.Rao PS. Which aortic coarctations should we balloon dilate? (Editorial). Am Heart J 1989;117:987-9.  Back to cited text no. 22      
23.Shaddy RE, Boucek MM, Sturtevant JE, Ruttenberg HD, Jaffe RB, Tani LY, et al. Comparison of angioplasty and surgery for unoperated coarctation of the aorta. Circulation 1993;87:793-9.  Back to cited text no. 23      
24.Waldman JD, Karp RB. How should we treat coarctation of the aorta? (Editorial). Circulation 1993;87:1043-5.  Back to cited text no. 24      
25.Rao PS. Balloon angioplasty for coarctation of the aorta in infancy. J Pediat 1987;110:713-8.  Back to cited text no. 25      
26.Reddington AN, Booth P, Shore DF, Rigby ML. Primary balloon dilatation of coarctation in neonates. Br Heart J 1990;64:277-81.  Back to cited text no. 26      
27.Rao PS. Balloon Angioplasty of Native Aortic Coarctation (Letter). Internat J Cardiol 1991;31:363-7.  Back to cited text no. 27      
28.Francis E, Gayathri S, Vaidyanathan B, Kannan BRJ, Krishna Kumar R. Emergency balloon dilation or stenting of critical coarctation of aorta in newborn and infants: An effective interim palliation. Ann Pediatr Card 2009;2:111-5.  Back to cited text no. 28    Medknow Journal  
29.Finley JP, Beaulieu RG, Nanton MA, Roy DL. Balloon catheter dilatation of coarctation of the aorta in young infants. Br Heart J 1983;50:411-5.  Back to cited text no. 29      
30.Brodsky S. Percutaneous balloon angioplasty: Treatment of congenital coarctation of the aorta and congenital pulmonic stenosis. Am J Dis Child 1984;54:1147-9.  Back to cited text no. 30      
31.Cooper RS, Ritter SB, Golinko RJ. Balloon dilatation angioplasty: Nonsurgical management of coarctation of the aorta. Circulation 1984;70:903-7.  Back to cited text no. 31      
32.Suαrez de Lezo J, Fernandez R, Sancho M, Concha M, ArizΫn J, Franco M, et al. Percutaneous transluminal angioplasty for aortic isthmic coarctation in infancy. Am J Cardiol 1984;54:1147-9.  Back to cited text no. 32      
33.Rao PS, Galal O, Smith PA, Wilson AD. Five- to nine-year follow-up results of balloon angioplasty of native aortic coarctation in infants and children. J Am Coll Cardiol 1996;27:462-70.  Back to cited text no. 33      
34.Salahuddin N, Wilson AD, Rao PS. An unusual presentation of coarctation of the aorta in infancy: Role of balloon angioplasty in the critically ill infant. Am Heart J 1991;122:1772-5.  Back to cited text no. 34      
35.Rao PS, Wilson AD, Brazy J. Transumbilical balloon coarctation angioplasty in neonates with critical aortic coarctation. Am Heart J 1992;124:1622-4.  Back to cited text no. 35      
36.Attia IM, Lababidi Z. Transumbilical balloon coarctation angioplasty. Am Heart J 1984;116:1623-4.  Back to cited text no. 36      
37.Rao PS. Current status of balloon angioplasty for neonatal and infant aortic coarctation. Prog Pediat Cardiol 2001;14:35-44.  Back to cited text no. 37      
38.Rao PS, Jureidini SB, Balfour IC, Singh GK, Chen SC. Severe aortic coarctation in infants less than 3 months: Successful palliation by balloon angioplasty. J Invasive Cardiol 2003;15:203-8.  Back to cited text no. 38      
39.Alyousef S, Khan A, Nihill M, Lababidi Z, Mullins C. Perkutane transvenose antegrade ballonangioplastic bei aortenisthmusstenose. Herz 1988;13:36-40.  Back to cited text no. 39      
40.Rao PS. Balloon angioplasty of native aortic coarctation (Letter). J Am Coll Cardiol 1992;20:756-7.  Back to cited text no. 40      
41.Lee HY, Reddy SCB, Rao PS. Evaluation of superficial femoral artery compromise and limb growth retardation following transfemoral artery balloon dilatations. Circulation 1997;95:976-80.  Back to cited text no. 41      
42.Vermillion RP, Lindy AR, Bengur AR, Beekman RH. Doppler evaluation of femoral artery in children after aortic balloon valvuloplasty and coarctation balloon angioplasty. Pediat Cardiol 1993;14:13-8.  Back to cited text no. 42      
43.Rao PS. Stents in treatment of aortic coarctation. J Am Coll Cardiol 1997;30:1853-5.  Back to cited text no. 43      
44.Rao PS. Stents in the management of congenital heart disease in pediatric and adult patients. Indian Heart J 2001;53:714-30.  Back to cited text no. 44      
45.Suαrez de Lezo J, Pan M, Romero M, Medina A, Segura J, Lafuente M, et al. Immediate and follow-up findings after stent treatment for severe coarctation of aorta. Am J Cardiol 1999;83:400-6.  Back to cited text no. 45      
46.Al-Ata J, Arfi AM, Hussain A, Kouatly A, Galal MO. Stent angioplasty: An effective alternative in selected infants with critical native aortic coarctation. Pediat Cardiol 2007;28:183-92.  Back to cited text no. 46      
47.Schaeffler R, Kolax T, Hesse C, Peuster M. Implantation of stents for treatment of recurrent and native coarctation in children weighing less than 20 kilograms. Cardiol Young 2007;17:617-22.  Back to cited text no. 47      
48.Zanjani KS, Sabi T, Moysich A, Ovroutski S, Peters B, Miera O, et al. Feasibility and efficacy of stent redilatation in aortic coarctation. Catheter Cardiovasc Interv 2008;72:552-6.  Back to cited text no. 48      
49.Mullins CE. Inappropriate stents: Primary cause of failure of stent redilation in coarctation of the aorta. Catheter Cardiovasc Interv 2008;72:557-8.  Back to cited text no. 49      
50.Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 2000;102:399-404.  Back to cited text no. 50      
51.Schranz D, Zartner P, Michel-Behnke I, Akinturk H. Bioabsorbable metal stents for percutaneous treatment of critical recoarctation of the aorta in a newborn. Catheter Cardiovasc Interv 2006;67:671-3.  Back to cited text no. 51      
52.Ewert P, Peters B, Nagdyman N, Miera O, Kόhne T, Berger F. Early and mid-term results with the growth stent - a possible concept for transcatheter treatment of aortic coarctation from infancy to adulthood by stent implantation? Catheter Cardiovasc Interv 2008;71:120-6.  Back to cited text no. 52      
53.Rao PS. Stents in the management of aortic coarctation in young children (Editorial). J Am Coll Cardiol 2009;2:884-6.  Back to cited text no. 53      

Top
Correspondence Address:
P Syamasundar Rao
Division of Pediatric Cardiology, The University of Texas/Houston Medical School, 6410 Fannin Street, UTPB Suite # 425, Houston, TX 77030
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-2069.58312

Rights and Permissions



This article has been cited by
1 Cheatham platinum stent implantation in children with coarctation of the aorta: single-centre short-term, intermediate-term, and long-term results from Turkey
Ali Baykan,Nazmi Narin,Abdullah Ozyurt,Mustafa Argun,Ozge Pamukcu,Ertugrul Mavili,Saadettin Sezer,Sertac H. Onan,Kazim Uzum
Cardiology in the Young. 2013; : 1
[Pubmed] | [DOI]



 

Top